TASTAD CAROLYN M 4
4 · PROCTER & GAMBLE Co · Filed Mar 3, 2022
Insider Transaction Report
Form 4
TASTAD CAROLYN M
CEO - Health Care
Transactions
- Sale
Common Stock
[F1][F2]2022-03-01$153.51/sh−3,730$572,597→ 28,156.066 total - Award
Restricted Stock Units
[F4][F5]2022-02-15+38.811→ 658.917 total→ Common Stock (38.811 underlying)
Holdings
- 5,886.202(indirect: By Trust)
Common Stock
[F3] - 1,993.282(indirect: By Spouse)
Common Stock
- 667.84(indirect: By Trust)
Common Stock
[F3]
Footnotes (5)
- [F1]Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.
- [F2]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F3]Reflects adjustment to PST through December 31, 2021.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Signature
/s/ Aaron B. Shepherd, attorney-in-fact for Carolyn M. Tastad|2022-03-03